全文获取类型
收费全文 | 32129篇 |
免费 | 3060篇 |
国内免费 | 1302篇 |
专业分类
耳鼻咽喉 | 317篇 |
儿科学 | 593篇 |
妇产科学 | 333篇 |
基础医学 | 4028篇 |
口腔科学 | 563篇 |
临床医学 | 3271篇 |
内科学 | 5558篇 |
皮肤病学 | 715篇 |
神经病学 | 1891篇 |
特种医学 | 1938篇 |
外国民族医学 | 5篇 |
外科学 | 3815篇 |
综合类 | 3502篇 |
现状与发展 | 5篇 |
一般理论 | 5篇 |
预防医学 | 2099篇 |
眼科学 | 711篇 |
药学 | 3262篇 |
10篇 | |
中国医学 | 1229篇 |
肿瘤学 | 2641篇 |
出版年
2024年 | 54篇 |
2023年 | 300篇 |
2022年 | 780篇 |
2021年 | 1129篇 |
2020年 | 811篇 |
2019年 | 960篇 |
2018年 | 1087篇 |
2017年 | 962篇 |
2016年 | 1262篇 |
2015年 | 1637篇 |
2014年 | 1907篇 |
2013年 | 2185篇 |
2012年 | 2789篇 |
2011年 | 2830篇 |
2010年 | 2019篇 |
2009年 | 1765篇 |
2008年 | 1934篇 |
2007年 | 1856篇 |
2006年 | 1683篇 |
2005年 | 1513篇 |
2004年 | 1413篇 |
2003年 | 1442篇 |
2002年 | 1273篇 |
2001年 | 762篇 |
2000年 | 517篇 |
1999年 | 331篇 |
1998年 | 207篇 |
1997年 | 203篇 |
1996年 | 123篇 |
1995年 | 83篇 |
1994年 | 93篇 |
1993年 | 46篇 |
1992年 | 62篇 |
1991年 | 64篇 |
1990年 | 44篇 |
1989年 | 51篇 |
1988年 | 29篇 |
1987年 | 41篇 |
1986年 | 31篇 |
1985年 | 17篇 |
1984年 | 23篇 |
1983年 | 15篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 14篇 |
1977年 | 11篇 |
1974年 | 9篇 |
1971年 | 10篇 |
1969年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
2.
3.
Moderate sedatives have been increasingly used to improve patient comfort during flexible bronchoscopy (FB). However, routine use of moderate sedation during FB is controversial because its efficacy and safety are not well established.This study aims to evaluate the efficacy and safety of moderate sedation during FB.A search was made of Medline, EMBASE, and the Cochrane Library to May 2014.Randomized controlled trials (RCTs) and quasi-RCTs were included.The main analysis was designed to examine the efficacy of moderate sedation during FB in sedation than no-sedation.The willingness to repeat FB was significantly more in sedation than no-sedation (odds ratio [OR] 2.30; 95% confidence interval [CI] 1.11–4.73; P = 0.02; I2 = 22.5). The duration of FB was shorter in sedation group than no-sedation group (standardized mean difference [SMD] −0.21; 95% CI −0.38 to −0.03; P = 0.02; I2 = 78.3%). Event of hypoxia was not significantly different between sedation and no-sedation groups (OR 0.86; 95% CI 0.42–1.73; P = 0.67; I2 = 0%). The SpO2 during procedure was not different between sedation and no-sedation groups (SMD −0.14; 95% CI −0.37 to 0.08; P = 0.21; I2 = 49.9%). However, in subgroup analysis without supplemental oxygen, the SpO2 was significantly lower in sedation than no-sedation group (SMD −0.45; 95% CI −0.78 to −0.11; P = 0.01; I2 = 0.0%).According to this meta-analysis, moderate sedation in FB would be useful in patients who will require repeated bronchoscopies as well as safe in respiratory depression. To our knowledge, although the various sedative drugs are already used in the real field, this analysis was the first attempt to quantify objective results. We anticipate more definite and studies designed to elucidate standardized outcomes for moderate sedation in FB. 相似文献
4.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
5.
6.
7.
8.
目的采用Meta分析方法评价18F-脱氧葡萄糖正电子发射计算机体层摄影(18F-FDG PET/CT)和增强CT(CECT)诊断经导管肝动脉化疗栓塞术(TACE)术后存活或复发病灶的临床价值。方法根据PRISMA报告规范开展Meta分析。检索PubMed、Embase、Cochrane Library、Web of Science、中国知网、万方和维普数据库中18F-FDG PET/CT和CECT诊断TACE术后存活或复发病灶的临床研究,时间至2019-04。由2位研究人员独立筛选文献、提取资料,根据诊断准确性研究质量评价工具-2(QUADAS-2)评价纳入研究的偏倚风险后,采用Stata 12.0软件进行Meta分析,计算其汇总敏感度(Sen)和特异度(Spe),绘制受试者工作特征曲线(SROC)并计算曲线下面积(AUC)。结果共纳入10篇18F-FDG PET/CT及13篇CECT诊断TACE术后存活或复发病灶的原始研究,分别包括322例患者的467个病灶和748例患者的943个病灶。Meta分析显示,18F-FDG PET/CT诊断TACE术后存活或复发病灶的Sen=0.92(95%CI为0.87~0.94)、Spe=0.95(95%CI为0.82~0.99)、AUC=0.97(95%CI为0.93~0.99);CECT诊断TACE术后存活或复发病灶的Sen=0.72(95%CI为0.66~0.78)、Spe=0.99(95%CI为0.93~1.00)、AUC=0.87(95%CI为0.83~0.89)。此外,CECT诊断TACE术后存活或复发Sen(Z=2.34,P=0.02)和AUC(Z=2.21,P=0.03)值低于18F-FDG PET/CT,差异有统计学意义。结论相比于CECT,18F-FDG PET/CT对TACE术后存活或复发病灶具有较高诊断效能,可视为TACE术后存活或复发病灶有效的影像学诊断方法。 相似文献
9.
Micro‐evolution of the hepatitis B virus genome in hepatitis B e‐antigen‐positive carriers: Comparison of genotypes B and C at various immune stages 下载免费PDF全文
10.